Evidence map›Paper›PMID 35352121›Full record

ArticleInternational journal of epidemiology2022

No increased risk of mature B-cell non-Hodgkin lymphoma after Q fever detected: results from a 16-year ecological analysis of the Dutch population incorporating the 2007-2010 Q fever outbreak.

Jesper M Weehuizen, Sonja E van Roeden, Sander J Hogewoning, Wim van der Hoek, Marc J M Bonten, Andy I M Hoepelman, Chantal P Bleeker-Rovers, Peter C Wever, Jan Jelrik Oosterheert

Open access · hybridAbstract read
In one paragraph

Article in International journal of epidemiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Identification and Characterization of an HtrA Sheddase Produced byInternational journal of molecular sciences · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Jesper M WeehuizenDepartment of Internal Medicine and Infectious Diseases, University Medical Centre Utrecht and Utrecht University, Utrecht, Netherlands.ORCID 0000-0001-9419-216X
Sonja E van RoedenDepartment of Internal Medicine and Infectious Diseases, University Medical Centre Utrecht and Utrecht University, Utrecht, Netherlands.
Sander J HogewoningNetherlands Comprehensive Cancer Organisation, Utrecht, Netherlands.
Wim van der HoekCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
Marc J M BontenDepartment of Medical Microbiology, University Medical Centre Utrecht and Utrecht University, Utrecht, Netherlands.
Andy I M HoepelmanDepartment of Internal Medicine and Infectious Diseases, University Medical Centre Utrecht and Utrecht University, Utrecht, Netherlands.
Chantal P Bleeker-RoversDepartment of Internal Medicine and Infectious Diseases, Radboud University Medical Centre and Radboud Expertise Centre for Q fever, Nijmegen, Netherlands.
Peter C WeverDepartment of Medical Microbiology and Infection Control, Jeroen Bosch Hospital, 's-Hertogenbosch, Netherlands.
Jan Jelrik OosterheertDepartment of Internal Medicine and Infectious Diseases, University Medical Centre Utrecht and Utrecht University, Utrecht, Netherlands.
Utrecht University · NLJeroen Bosch Ziekenhuis · NLNational Institute for Public Health and the Environment · NLNetherlands Comprehensive Cancer Organisation · NLRadboud University Nijmegen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA causative role of Coxiella burnetii (the causative agent of Q fever) in the pathogenesis of B-cell non-Hodgkin lymphoma (NHL) has been suggested, although supporting studies show conflicting evidence. We assessed whether this association is present by performing a detailed analysis on the risk of mature B-cell NHL after Q fever during and after the largest Q fever outbreak reported worldwide in the entire Dutch population over a 16-year period.

methodsWe performed an ecological analysis. The incidence of mature B-cell NHL in the entire Dutch population from 2002 until 2017 was studied and modelled with reported acute Q fever cases as the determinant. The adjusted relative risk of NHL after acute Q fever as the primary outcome measure was calculated using a Poisson regression.

resultsBetween January 2002 and December 2017, 266 050 745 person-years were observed, with 61 424 diagnosed with mature B-cell NHL. In total, 4310 persons were diagnosed with acute Q fever, with the highest incidence in 2009. The adjusted relative risk of NHL after acute Q fever was 1.02 (95% CI 0.97-1.06, P = 0.49) and 0.98 (95% CI 0.89-1.07, P = 0.60), 0.99 (95% CI 0.87-1.12, P = 0.85) and 0.98 (95% 0.88-1.08, P = 0.67) for subgroups of diffuse large B-cell lymphoma, follicular lymphoma or B-cell chronic lymphocytic leukaemia, respectively. Modelling with lag times (1-4 years) did not change interpretation.

conclusionWe found no evidence for an association between C. burnetii and NHL after studying the risk of mature B-cell NHL after a large Q fever outbreak in Netherlands.

Indexed as

Coxiella burnetiiLymphoma, Non-HodgkinQ FeverDisease OutbreaksHumansRiskCoxiella burnetiiDutch Q fever outbreaklymphomagenesismature B-cell non-Hodgkin lymphomaQ fever

Identifiers

PMID35352121
PMCPMC9557853
OpenAlexW4220774832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.